Inhibiting myeloperoxidase prevents onset and reverses established high-fat diet-induced microvascular insulin resistance
Authors:
- 1 December 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 317 (6) , E1063-E1069
Abstract
A high-fat diet (HFD) can rapidly recruit neutrophils to insulin target tissues and within days induce microvascular insulin resistance (IR). Myeloperoxidase (MPO) is highly enriched in neutrophils, can inhibit nitric oxide-mediated vasorelaxation in vitro and is associated with increased cardiovascular disease risk. AZD5904 irreversibly inhibits MPO and in human clinical trials. MPO knockout, or chemical inhibition, blunts HFD-induced metabolic IR in mice. Whether MPO affects microvascular IR or muscle metabolic insulin sensitivity in vivo is unknown. We used contrast-enhanced ultrasound and the euglycemic insulin clamp to test whether inhibiting MPO could prevent the development or reverse established HFD-induced metabolic and/or microvascular IR in Sprague-Dawley rats. Two weeks of HFD feeding blocked insulin-mediated skeletal muscle capillary recruitment, inhibited glucose utilization, and insulin signaling to muscle. Continuous subcutaneous AZD5904 infusion during the 2 wk selectively blocked HFD’s microvascular effect. Furthermore, AZD5904 infusion during the last 2 of 4 wk of HFD feeding restored microvascular insulin sensitivity but not metabolic IR. We conclude that inhibiting MPO selectively improves vascular IR. This selective microvascular effect may connote a therapeutic potential for MPO inhibition in the prevention of vascular disease/dysfunction seen in IR humans.Keywords
Funding Information
- AstraZeneca (no number assigned)
This publication has 26 references indexed in Scilit:
- Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the ‘common soil’ hypothesisCardiovascular Diabetology, 2018
- Endothelial-Transcytosed Myeloperoxidase Promotes Endothelial Dysfunction in an Oxidant Specific Manner: Novel Protective Actions of Thiocyanate and NitriteFree Radical Biology and Medicine, 2016
- Glucagon-Like Peptide 1 Recruits Muscle Microvasculature and Improves Insulin’s Metabolic Action in the Presence of Insulin ResistanceDiabetes, 2014
- Inflammation and Lipid Signaling in the Etiology of Insulin ResistanceCell Metabolism, 2012
- Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In VivoDiabetes, 2011
- Neutrophils in the activation and regulation of innate and adaptive immunityNature Reviews Immunology, 2011
- Inflammation and metabolic disordersNature, 2006
- Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κBNature Medicine, 2005
- Myeloperoxidase, a Leukocyte-Derived Vascular NO OxidaseScience, 2002
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995